Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.97% | -11.28% | -27.59% | -26.82% | -26.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.97% | -11.28% | -27.59% | -26.82% | -26.84% |
| Cost of Revenue | 14.76% | -11.93% | -30.99% | -30.28% | -30.06% |
| Gross Profit | 25.19% | -8.92% | -13.51% | -11.77% | -11.82% |
| SG&A Expenses | 3.18% | -6.32% | -34.50% | -33.65% | -31.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.16% | -10.46% | -32.36% | -31.80% | -31.14% |
| Operating Income | 29.42% | 3.58% | 60.93% | 58.55% | 51.17% |
| Income Before Tax | 43.76% | 45.43% | 65.38% | 67.63% | -12.56% |
| Income Tax Expenses | 88.98% | 87.53% | 90.99% | 87.11% | 12.90% |
| Earnings from Continuing Operations | 42.65% | 44.39% | 64.52% | 66.97% | -13.64% |
| Earnings from Discontinued Operations | 1,726.11% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 178.49% | 61.43% | 46.99% | 51.30% | -37.03% |
| EBIT | 29.42% | 3.58% | 60.93% | 58.55% | 51.17% |
| EBITDA | 35.63% | 1.89% | 71.42% | 67.22% | 58.03% |
| EPS Basic | 170.67% | 63.33% | 49.45% | 53.55% | -31.04% |
| Normalized Basic EPS | 25.36% | -93.85% | 62.37% | 67.34% | 58.80% |
| EPS Diluted | 170.24% | 63.36% | 50.59% | 53.75% | -30.28% |
| Normalized Diluted EPS | 25.36% | -93.02% | 62.42% | 67.38% | 58.84% |
| Average Basic Shares Outstanding | 5.30% | 5.20% | 5.14% | 5.11% | 4.94% |
| Average Diluted Shares Outstanding | 5.30% | 2.86% | 2.77% | 2.71% | 2.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |